...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >QUENCHING OF N-NITROSOPYRROLIDINE INDUCED HEPATOCELLULAR CARCINOMA ON POST TREATMENT WITH THE HELICTERES ISORA
【24h】

QUENCHING OF N-NITROSOPYRROLIDINE INDUCED HEPATOCELLULAR CARCINOMA ON POST TREATMENT WITH THE HELICTERES ISORA

机译:胰岛素治疗后治疗对N-亚硝基水杨碱诱导的肝细胞癌的猝灭作用

获取原文

摘要

Objective: The present study was aimed at probing the protective potential of Helicteres isora hydroethanolic stem bark extract (HIHSBE) against N-nitrosopyrrolidine (NPYR) induced hepatocellular carcinoma (HCC) in Swiss albino male mice. Method: Mice were divided into six groups of six mice in each. Hepatocellular carcinoma (HCC) was induced by single intraperitoneal injection of the carcinogen nitrosopyrrolidine (NPYR). Followed by the subcutaneous injection of carbon tetrachloride (CCl4). Carcinogen treated mice were then orally administered with Helicteres isora hydroethanolic stem bark extract (HIHSBE) at a dose of 100 and 200 mg/kg once daily for 4 weeks followed by investigation of liver injury markers like alanine transaminase (ALT), aspartate transaminase (AST), alanine phosphatase (ALP), gamma glutamyl transferase (GGT), Lactate dehydrogenase (LDH). Tumor markers alpha fetoprotein and carcinoembryonic antigen were determined in serum. Level of catalase (CAT), reduced glutathione (GSH), glutathione-s- transferase (GST) and lipid peroxidation were also estimated. Results: The level of liver injury markers and antioxidant enzymes decreased in the liver tissue of NPYR treated mice compared to normal control mice. However, HIHSBE post treatment increased the level of these enzymes compared to only carcinogen treated mice. HIHSBE also lowered the level of tumor markers and lipid peroxidation in serum and liver tissue of mice bearing HCC respectively. Histological studies also supported biochemical investigations. Conclusion: The chemopreventive effect of HIHSBE is well supported in our study as it hinders the development of HCC by interacting with ROS during carcinogenesis and thus counterbalancing the antioxidant defense system as analyzed.
机译:目的:本研究旨在探索瑞士白芥子油菜茎干提取物(HIHSBE)对N-亚硝基吡咯烷酮(NPYR)诱导的瑞士白化病雄性小鼠肝细胞癌(HCC)的保护潜力。方法:将小鼠分成六组,每组六只小鼠。腹膜内注射致癌物亚硝基吡咯烷酮(NPYR)可诱发肝细胞癌(HCC)。皮下注射四氯化碳(CCl4)。然后,每天以100和200 mg / kg的剂量口服Helicteres isora氢乙醇茎干树皮提取物(HIHSBE),对致癌物治疗的小鼠口服,持续4周,然后研究肝损伤标记物,如丙氨酸转氨酶(ALT),天冬氨酸转氨酶(AST) ),丙氨酸磷酸酶(ALP),γ-谷氨酰转移酶(GGT),乳酸脱氢酶(LDH)。在血清中测定肿瘤标志物甲胎蛋白和癌胚抗原。还估计了过氧化氢酶(CAT),还原型谷胱甘肽(GSH),谷胱甘肽S-转移酶(GST)和脂质过氧化的水平。结果:与正常对照组相比,NPYR治疗小鼠的肝脏组织中肝损伤标志物和抗氧化酶的水平降低。但是,与仅用致癌物治疗的小鼠相比,HIHSBE治疗后增加了这些酶的水平。 HIHSBE还分别降低了HCC小鼠血清和肝组织中肿瘤标志物的水平和脂质过氧化作用。组织学研究也支持生化研究。结论:HIHSBE的化学预防作用在我们的研究中得到了很好的支持,因为它通过在致癌过程中与ROS相互作用阻碍了HCC的发展,从而平衡了抗氧化剂的防御系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号